The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Partnership Amplifies Advocacy Reach

Partnership Amplifies Advocacy Reach

January 23, 2022 • By From the College

  • Tweet
  • Email
Print-Friendly Version / Save PDF

The ACR has had many critical recent advocacy successes—some primarily through our own advocacy efforts, but others due in part to the ACR’s work in broader coalitions. One of the most important of these relationships is with the American Medical Association (AMA), the country’s largest and most visible physician society. Given our relatively small subspecialty, the ACR’s involvement with the AMA provides rheumatology with a megaphone to amplify our voice at both federal and state levels.

You Might Also Like
  • Maintain Rheumatology’s Seat at the AMA Table
  • AMA House of Delegates Meeting Postponed Due to COVID-19, Advocacy Efforts Continue
  • The Impact of Joining the AMA
Also By This Author
  • Advocacy in Action: How the ACR Is Working for You

2022 is a particularly critical year for the ACR’s representation in AMA policy bodies and its ability to participate in and influence the AMA’s policy decisions. We are entering our five-year membership review, in which the ACR must demonstrate enough of its members have joined or renewed their AMA membership. We cannot afford to be sidelined and lose rheumatology’s voice with the AMA at this critical juncture. We need all U.S. ACR members’ help by joining or renewing their AMA membership to protect our members and our subspecialty, as well as our patients’ access to care.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

This representation allows the ACR to add to AMA official policies and spur AMA action on issues important to our specialty. In recent years, the ACR has authored and led or cosponsored actions on key rheumatology issues, including:

  • Pharmacy benefit manager reform;
  • Copay accumulator policies;
  • Stakeholder engagement in Medicare Administrative Contractor Policy;
  • Complex treatment administration and reimbursement;
  • Fighting payer financial incentives to patients for switching treatments;
  • Stopping mandatory payment models from the Centers for Medicare & Medicaid Services Innovation Center and elsewhere;
  • Home infusion issues;
  • Biosimilar interchangeability;
  • Drug pricing issues;
  • Private payers and consultation codes;
  • Prior authorization and Medicare Advantage; and
  • Step therapy reform.

By joining or renewing your AMA membership, you will help rheumatology maintain its seat at the table where key policies are made. The ACR will be able to continue to participate in many areas of the AMA that directly affect you and your patients. Key groups include:

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE
  • House of Delegates, the legislative and policy-making body of the AMA. Resolutions have the potential to become official policy of the AMA or directives that determine where the AMA focuses its advocacy and policy efforts as the largest and most visible physician association in the country;
  • Relative Update Committee (RUC), which advises Medicare on how to value a physician’s work; and
  • Current Procedural Terminology (CPT) Advisory Committee, which determines codes and billing for outpatient and office procedures.

The College’s collaboration with the AMA in these and other areas yields positive results for our members and our patients. In fact, many of the AMA’s stances and actions on issues of importance to the rheumatology community were initiated or influenced by the ACR’s involvement in the AMA’s House of Delegates and other processes.

Pages: 1 2 | Single Page

Filed Under: Legislation & Advocacy Tagged With: Advocacy, AMA House of Delegates (HOD), AMA membership, AMA Relative Value Update Committee (RUC)

You Might Also Like:
  • Maintain Rheumatology’s Seat at the AMA Table
  • AMA House of Delegates Meeting Postponed Due to COVID-19, Advocacy Efforts Continue
  • The Impact of Joining the AMA
  • ACR Leverages AMA Representation to Advance Rheumatology Issues

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)